logo
Targeted Conservation Efforts Help Restore Crashing Biodiversity

Targeted Conservation Efforts Help Restore Crashing Biodiversity

Forbes27-03-2025

A major review of over 67,000 animal species has found that with greater resource allocation, conservation can halt and reverse biodiversity loss.
European bison (Bison bonasus) are a coonservation success story. (Credit: JMrocek)
The planet is being confronted by a growing biodiversity crisis, with 28% of more than 160,000 assessed species threatened with extinction, and an estimated one million species facing this tragic fate due to human activities. And yet in the face of all this, conservation measures are providing promising results. But which actions make conservation efforts successful? This is the main question that a recent scientific review sought to answer.
To answer this question, a UK-based team of researchers published their analysis of more than 67,000 animal species that are either threatened or facing extinction to identify which sorts of conservation efforts are helping to bring them back from the brink. The researchers did this by evaluating data collected by the IUCN Red List for 67,217 animal species to specifically determine:
'We found that almost all the species that have moved from a more threatened category to a less threatened category have benefited from some sort of conservation measures,' observed the study's lead author, conservation biologist Ashley Simkins, a PhD student in the Department of Zoology at the University of Cambridge, where he is a member of King's College.
'It's a strong signal that conservation works.'
But according to the findings, these threatened or endangered animals did not benefit from just one conservation action, nor is there one main solution for responding to conservation issues for all species.
'Sadly there is no 'silver bullet' or one solution to avoiding declines,' Mr Simkins told me in email. 'Many species are declining due to human pressures, particularly from habitat loss or degradation (often driven by agricultural expansion) or unsustainable use of species.'
Although there is no 'one size fits all' solution, Mr Simkins and collaborators did uncover some commonalities shared by animal species that have conservation success stories. These commonalities that have helped many species recover include habitat protection, breeding programs, and legal protections. They also found that, many recovering species live in isolated areas, such as islands, where successful conservation efforts can be fully implemented without interference.
Iberian Lynx (Lynx pardinus), Almuradiel, Ciudad Real, Spain. (Credit: Diego Delso / CC BY-SA 4.0)
'While biodiversity loss is a genuine crisis, it's vital that we celebrate the success stories wherever and whenever we can,' Mr Simkins mentioned in email. 'It's so hard for a species to improve its conservation status, but with the right effort, we can turn things around.'
Several of the many conservation success stories worth mentioning include the Iberian lynx, Lynx pardinus, once the world's most endangered cat. This animal's population rebounded from just a few hundred individuals to a few thousand. Likewise, the kākāpō, Strigops habroptilus, a flightless nocturnal parrot from New Zealand, has benefited from imaginative and dedicated recovery programs. And the European bison, also known as the European wood bison or wisent, Bison bonasus, which was hunted to extinction in the wild by the early 20th century, now roam several countries in Eastern Europe, thanks to decades of devoted conservation efforts.
Similarly, some marine species also have inspirational conservation success stories to tell. Probably the most familiar are humpback and blue whales, which were driven to the brink of extinction not so long ago by commercial whaling, but are making a comeback after an international moratorium was enacted on whaling.
'Almost everyone will have their own favorite example of a conservation success story, whether it's the bald eagle in North America, or the red kite in the UK,' Mr Simkins mentioned. 'We need joint action to ensure these positive stories aren't the exception – they're the norm.'
Humpback Whale (Megaptera novaeangliae). Public domain.
Despite Mr Simkins' enthusiasm, these success stories are still comparatively rare: the study found that six times more species are declining rather than improving.
And this is why it is so important to identify what we can do to prevent population declines in vulnerable species before they become threatened. Indeed, much like for preventative medicine, identifying and adopting preventative conservation measures are preferable and more cost-effective than attempting to rescue a species after it is serious trouble.
'Humans have gotten pretty good at what could be considered 'A&E' conservation—focusing on species at very high risk of extinction,' Mr Simkins noted. 'What we're less good at is preventing species from becoming threatened in the first place. We need to move beyond treating the symptoms of biodiversity loss and start addressing the root causes.'
These root causes include habitat destruction, hunting and other forms of persecution, and the growing effects of the climate crisis.
'To avoid these declines, we need to find ways to alleviate these pressures on species, and work with stakeholders in these areas to find solutions that both provide what they need whilst minimising harms on wildlife,' Mr Simkins recommended in email. 'We also need greater funding to conservation to scale up actions if we want to ideally avoid or at least minimise declines.'
In their review, Mr Simkins and collaborators emphasize collective, locally driven conservation. For example, in Papua New Guinea, conservation biologists worked with local communities to replace hunting wild tree kangaroos with sustainable forms of animal protein, including farming chickens and fishing – an approach that benefits both people and wildlife.
'It's vital that we as conservationists are working with stakeholders, rather than dictating to them, whether that's an Indigenous community in Papua New Guinea or a farmer in Somerset,' Mr Simkins pointed out.
'Conservation doesn't have to be a zero-sum game – there are compromises that can benefit both the natural world and human society.'
This study provides a broad overview of which conservation actions are most helpful for recovering species and also highlights species that still require conservation interventions. It's important to note that although the study finds that actions taken to prevent species extinctions usually lead to improvements, it also finds that conservation actions rarely lead to full recovery of threatened species. Additionally, Mr Simkins and collaborators note that there still are gaps in the IUCN Red List data due to inconsistencies in assessment and documentation strategies across species. Thus, improving documentation of conservation actions that are currently underway and scaling up conservation efforts will be essential to assist the recovery of biodiversity.
The research collaboration for this work consisted of scientists from the University of Cambridge, BirdLife International, Oxford University, and Durham University, along with the IUCN, which maintains the world's largest database of the conservation status of the world's species known as the Red List.
'Despite huge losses and declines of species, we find conservation action has driven improvements in more than one hundred species, with almost all species improving in status having conservation actions in place,' Mr Simkins and collaborators write in their review (ref).
'This suggests with greater resource allocation, conservation can halt and reverse biodiversity loss.'
Ashley T. Simkins, William J. Sutherland, Lynn V. Dicks, Craig Hilton-Taylor, Molly K. Grace, Stuart H. M. Butchart, Rebecca A. Senior, and Silviu O. Petrovan (2025). Past conservation efforts reveal which actions lead to positive outcomes for species, PLOS Biology 23(3):e3003051 | doi:10.1371/journal.pbio.3003051
© Copyright by GrrlScientist | hosted by Forbes | LinkTr.ee
Socials: Bluesky | CounterSocial | Gab | LinkedIn | Mastodon Science | Spoutible | SubStack | Threads | Tribel | Tumblr | Twitter

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why the U.K. is betting $76 million on solar engineering to help cool the planet
Why the U.K. is betting $76 million on solar engineering to help cool the planet

Fast Company

time23 minutes ago

  • Fast Company

Why the U.K. is betting $76 million on solar engineering to help cool the planet

The climate crisis is worsening. Last year was the warmest on record, global sea ice levels are at a record low, and the economic toll of extreme natural disasters continues to mount. Just this week, the World Meteorological Organization said the global average temperature is likely to rise nearly 2 degrees Celsius above pre-industrial levels within the next five years, with 'growing negative impact on our economies, our daily lives, our ecosystems and our planet.' Experts are adamant that the only way to slow the warming is to stop burning the fossil fuels that create the greenhouse effect. And yet, in 2024, emissions reached a new high. As the WMO's Secretary-General Celeste Saulo put it: 'We are heading in the wrong direction.' And as the temperature rises, so does the chance that Earth's natural systems will cross thresholds that trigger irreversible and cascading destruction. The encroaching threat of these tipping points is why the British government's Advanced Research and Invention Agency (ARIA) is pouring £57 million ($76 million) into studying 'climate cooling approaches.' That's a fancy way of referring to climate geoengineering, or intentionally tinkering with the Earth's weather systems in an attempt to cool things down. More specifically, ARIA is examining whether we might be able to reflect some sunlight away from the surface of the Earth and back into space.

Family of late presenter and health guru Michael Mosley set up research fund
Family of late presenter and health guru Michael Mosley set up research fund

Yahoo

time2 hours ago

  • Yahoo

Family of late presenter and health guru Michael Mosley set up research fund

The family of healthy eating advocate, radio presenter and former Beaconsfield resident Michael Mosley has set up a research project to honour his memory. The 67-year-old journalist, who died while on holiday with his wife, Dr Clare Bailey Mosley, on the Greek island of Symi in June last year, was known for popularising diets and fronting science programmes. A new clinical research fellowship will be established in partnership with King's College London and the Chronic Disease Research Foundation (CDRF) to help improve the nation's metabolic health. Mosley's wife, Dr Clare Bailey Mosley, said: 'Michael was most proud of the work that he did in helping people to improve their metabolic health. 'It is increasingly clear that improving metabolic health decreases your risk of multiple chronic conditions, including type 2 diabetes, reducing blood pressure, cardiovascular disease, dementia, cancer and more. 'The Mosley family are thrilled that this fellowship will continue in his name to improve so many people's lives.' The Mosleys have been working with King's College London and the CDRF, who will administer the Michael Mosley Memorial Research Fund, to appoint a dedicated research scientist. The researcher will work directly with patients in hospitals and healthcare settings to discover the challenges they face and determine the most practical changes that can improve metabolic health. Professor Tim Spector, medical director of the CDRF and professor of genetic epidemiology at King's College London, said: 'Michael was a dear friend and we shared a passion for sharing knowledge to help people lead healthier, happier lives for longer. 'The funds raised for the fellow will embody his spirit, translating cutting-edge metabolic research from the lab to hospital wards, directly benefiting patients.' Many Beaconsfield residents, who occasionally rubbed shoulders with the local celebrity, joined several prominent figures in paying tribute to the popular celebrity 12 months ago, who had become a 'national treasure' through his work in innovating the science and healthcare space. Several locals shared their memories of spotting the TV doctor around the town, with Phil Barron remembering joint commutes with the 67-year-old between Bucks and London Marylebone, when he struck him as 'a genuinely nice, unassuming chap (with) no hint of arrogance'. Marcus Osborn described Mosley as 'a great British gentleman', while Heather Wicks, who said she would regularly see him out cycling around Beaconsfield, said his loss was 'so very sad'. Val Hardy, who once sat next to the well-known TV personality and his wife while out for a coffee, also said the news was 'very sad', while Claire Louise said her partner had met him while out and about and reaffirmed his description as a 'real gentleman'. During his career, Mosley hosted a number of science programmes and was a known advocate of intermittent fasting and the 5:2 diet. The Michael Mosley Fund JustGiving page can be found here:

Tezepelumab Curbs Oral Corticosteroid Use in Severe Asthma
Tezepelumab Curbs Oral Corticosteroid Use in Severe Asthma

Medscape

time2 hours ago

  • Medscape

Tezepelumab Curbs Oral Corticosteroid Use in Severe Asthma

The addition of tezepelumab to standard treatment allowed half the adults with severe asthma to discontinue their use of oral corticosteroids (OCS) after 1 year, according to new data from nearly 300 individuals. Tezepelumab, a human monoclonal antibody, has been associated with reduction in the use of OCS in patients with OCS-dependent asthma, David J. Jackson, MD, professor and clinical director, Guy's Severe Asthma Centre at Guy's Hospital King's College London, London, England, and colleagues wrote in an abstract presented at American Thoracic Society (ATS) 2025 International Conference. Many patients with severe asthma take OCS, but previous research has shown associations between extended OCS use and increased risk for a range of side effects including osteoporosis and fractures, hypertension, and infections, and more strategies are needed to help these patients reduce OCS use, the researchers noted. 'We know prolonged oral corticosteroid use leads to adverse effects, including bone, cardiovascular, metabolic, gastrointestinal and psychiatric disorders, and adrenal insufficiency,' Jackson said in an interview. 'The WAYFINDER trial is a multicenter, open-label, single-arm trial evaluating the efficacy and safety of tezepelumab compared to placebo in severe asthma patients who require maintenance use of OCS alongside their standard treatment,' he said. A previous phase 3 OCS-sparing study known as SOURCE did not meet its primary endpoint, but patients with baseline blood eosinophil counts ≥ 150 cels/μL who received tezepelumab achieved a reduction in daily maintenance OCS (mOCS) dose compared with placebo patients, the researchers wrote in their abstract. 'The WAYFINDER trial was designed to accelerate data collection and specifically address the complexities in the SOURCE trial design that may have contributed to the result of the primary endpoint,' Jackson told Medscape Medical News . The WAYFINDER trial enrolled 298 adults with severe asthma who had received OCS for at least 3 months before starting the study. All participants received 210 mg of subcutaneous tezepelumab every 4 weeks for up to 52 weeks after a 4-week induction period. The co-primary endpoints were the proportion of patients who reduced their daily mOCS to 5 mg/d or less or discontinued OCS without loss of asthma control. A total of 273 patients completed the study; the mean baseline mOCS was 10.8 mg/d, and patients were assessed at 28 weeks and 52 weeks. Overall, 88.9% and 89.9% of patients reduced their mOCS to 5 mg/d or less by week 28 and week 52, respectively, while 32.2% and 50.3% discontinued OCS at these time periods, respectively. In a post hoc analysis, 82.2% of patients whose reason for systemic corticosteroids was related to adrenal insufficiency achieved an mOCS dose of 5 mg/d or less without loss of asthma control at week 52. The study was limited by the open-label design, but the safety profile was consistent with previous studies of tezepelumab, researchers said. A 2023 meta-analysis of safety data on tezepelumab for uncontrolled asthma showed that the most common adverse events were nasopharyngitis, headache, and bronchitis, and most AEs occurred within a month of starting tezepelumab. Rates of serious adverse events were lower in patients receiving tezepelumab than those receiving placebo in a pooled analysis. The standout findings from the study are the clinically meaningful reductions in maintenance OCS use or complete discontinuation achieved with tezepelumab among a broad severe asthma patient population, Jackson told Medscape Medical News . In addition, two thirds of participants remained exacerbation-free despite OCS dose reductions, and the OCS-sparing effect of tezepelumab was observed across pre-specified patient subgroups, including those defined by baseline blood eosinophil counts (BEC), fractional exhaled nitric oxide (FeNO) level and allergy status, Jackson said. 'These findings reinforce tezepelumab's efficacy in severe asthma as the first and only biologic targeting thymic stromal lymphopoietin (TSLP) with demonstrated efficacy for severe asthma patients across phenotypes and irrespective of biomarker levels including BEC, allergic status, and FeNO,' he said. Improving Short-Term Health and Long-Term Wellness 'For people living with severe asthma, achieving stable control and reducing or eliminating reliance on oral corticosteroids is a critical goal, not only for respiratory health but also for long-term well-being,' Jackson told Medscape Medical News . 'By showing the benefit of targeting TSLP at the top of the inflammatory cascade and controlling asthma effectively with tezepelumab, we may be able to reduce these risks from OCS and significantly improve control for patients living with severe asthma,' Jackson said. 'We look forward to sharing a manuscript in the future for the phase 3b WAYFINDER study,' he added. Support for Steroid-Sparing The current study highlights an important population: Patients with asthma who are dependent on OCS, said Sucharita Kher, MD, pulmonologist and vice chair of clinical operations and quality for the Department of Medicine at Tufts Medical Center, in an interview. The endpoint tapering OCS without loss of asthma control is clinically meaningful because of the known side effects of OCS, said Kher, who was not involved in the study. The results were not unexpected, but more details on whether patients with eosinophils below 150 cells/µL also benefitted from tezepelumab would be helpful, Kher noted. The data are exciting because they suggest another option for patients with OCS dependent asthma, said Kher. 'The data also guide clinicians to adopt a strategy to wean patients off OCS when on tezepelumab with the goal of reducing OCS exposure and hence, side effects of prolonged OCS use,' she said. 'We know that OCS have side effects and negative consequences on factors including bone health, blood pressure, and blood sugar control and infection risk,' she added. Potential barriers to expanding the use of tezepelumab for reducing OCS in asthma patients exist at the patient and healthcare systems levels, Kher told Medscape Medical News . Patient-level barriers include cost sharing, worry/hesitancy about injections, lack of specialty access, and patient health literacy, she said. In addition, healthcare system barriers include a lack of knowledge on the part of primary care providers, and even some specialty physicians, of the benefits of biologics for severe asthma, said Kher. Other potential challenges include limited infrastructure in clinician offices, such as trained personnel and staff to navigate prior auth/insurance mandates, pre-authorization barriers, and denials based on tiers by insurance companies, she noted. 'Overcoming the barriers requires a multipronged approach, improving awareness and education for healthcare professionals, improve access to specialty care for patients, and advocacy to reduce the processes for insurance approvals,' Kher said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store